The median raphe nucleus in anxiety revisited

Journal of Psychopharmacology

Volumn 27, Issue 12, 2013, Pages 1107-1115

  Andrade, Telma G C S ^a   Zangrossi, Hélio ^b   Graeff, Frederico G ^b,c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Institute of Neurosciences and Behavior (INeC)   (Brazil)

Author keywords

anxiety and panic; dorsal raphe nucleus; hippocampus; Median raphe nucleus; serotonin

Indexed keywords

SEROTONIN;

ANIMAL BEHAVIOR; ANXIETY; BRAIN FUNCTION; DEFENSIVE BEHAVIOR; ELEVATED T MAZE; EXECUTIVE FUNCTION; HUMAN; MAZE TEST; MEDIAN RAPHE NUCLEUS; NEUROANATOMY; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC TRANSMISSION; ANIMAL; AVOIDANCE BEHAVIOR; DISEASE MODEL; HIPPOCAMPUS; METABOLISM; NERVE CELL; PANIC; PATHOPHYSIOLOGY; PHYSIOLOGY; RAPHE NUCLEUS; RAT;

ANIMALS; ANXIETY; AVOIDANCE LEARNING; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MAZE LEARNING; NEURONS; PANIC DISORDER; RAPHE NUCLEI; RATS; SEROTONIN;

EID: 84887843457     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113499208     Document Type: Review

References (100)

1. Almada RC, Borelli KG, Albrechet-Souza L, et al. Serotonergic mechanisms of the median raphe nucleus-dorsal hippocampus in conditioned fear: Output circuit involves the prefrontal cortex and amygdala. Behav Brain Res. 2009 ; 203: 279-287
2. Andrade TGCS, Graeff FG. Effect of electrolytic and neurotoxic lesions of the median raphe nucleus on anxiety and stress. Pharmacol Biochem Behav. 2001 ; 70: 1-14
3. Andrade TGCS, Avanzi V, Graeff FG. Effect of estradiol benzoate microinjection into median raphe nucleus on contextual conditioning. Behav Brain Res. 2009 ; 204: 112-116
4. Andrade TGCS, Macedo CEA, Zangrossi H, et al. Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. Behav Brain Res. 2004 ; 153: 55-60
5. Andrade TGCS, Nakamuta JS, Avanzi V, et al. Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors. Behav Brain Res. 2005 ; 163: 18-25
6. Andrade TGCS, Silva AM, Silva CL, et al. Effect of electrolytic lesion of the median raphe nucleus on behavioral and physiological measures of stress. Acta Physiol Pharmacol Ther Latinoam. 1999 ; 49: 279-289
7. Andrews N, Hogg S, Gonzalez LE, et al. 5-HT1A receptors in the median raphe nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviours respectively. Eur J Pharmacol. 1994 ; 264: 259-264
8. Asin KE, Fibiger HC. An analysis of neuronal elements within the median nucleus of the raphe that mediate lesion-induced increases in locomotor activity. Brain Res. 1983 ; 268: 211-223
9. Atack JR, Hutson PH, Collinson N, et al. Anxiogenic properties of an inverse agonist selective for a3 subunit-containing GABA A receptors. Br J Pharmacol. 2005 ; 144: 357-366
10. Avanzi V, Brandão ML. Activation of somatodendritic 5-HT1A autoreceptors in the median raphe nucleus disrupts the contextual conditioning in rats. Behav Brain Res. 2001 ; 126: 175-184
11. Avanzi V, Castilho VM, Andrade TGCS, et al. Regulation of contextual conditioning by median raphe nucleus. Brain Res. 1998 ; 790: 178-184
12. Azmitia EC, Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol. 1978 ; 179: 641-668
13. Bannerman DM, Rawlins JNP, McHugh SB, et al. Regional dissociations within the hippocampus-memory and anxiety. Neurosci Behav Rev. 2004 ; 28: 273-283
14. Beck SG, Pan YZ, Akanwa AC, et al. Median and dorsal raphe neurons are not electrophysiologically identical. J Neurophysiol. 2004 ; 91: 994-1005
15. Bertoglio LJ, Joca SRL, Guimarães FS. Further evidence that anxiety and memory are regionally dissociated within the hippocampus. Behav Brain Res. 2006 ; 175: 183-188
16. Borelli KG, Gárgaro AC, Santos JM, et al. Effects of inactivation of serotonergic neurons of the median raphe nucleus on learning and performance of contextual fear conditioning. Neurosci Lett. 2005 ; 387: 105-110
17. Bosker FJ, de Winter TY, Klompmakers AA, et al. Flesinoxan dose-dependently reduces extracellular 5-hydroxytryptamine (5-HT) in rat median raphe and dorsal hippocampus through activation of 5-HT1A receptors. J Neurochem. 1996 ; 66: 2546-2555
18. Calizo LH, Akanwa A, Ma X, et al. Raphe serotonin neurons are not homogenous: Electrophysiological, morphological and neurochemical evidence. Neuropharmacology. 2011 ; 61: 524-543
19. Canto-de-Souza A, Nunes-de-Souza RL, et al. Anxiolytic-like effect of WAY-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: Influence of prior test experience. Brain Res. 2002 ; 928: 50-59
20. Carli M, Samanin R. Potential anxiolytic properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin 1A receptor agonist. Psychopharmacology. 1988 ; 94: 84-91
21. Carli M, Prontera C, Samanin R. Evidence that central 5-hydroxytryptaminergic neurones are involved in the anxiolytic activity of buspirone. Br J Pharmacol. 1989 ; 96: 829-836
22. Cervo L, Mocaër E, Bertaglia A, et al. Roles of 5-HT1A receptors in the dorsal raphe and dorsal hippocampus in anxiety assessed by the behavioral effects of 8-OH-DPAT and S 15535 in a modified Geller-Seifter conflict model. Neuropharmacology. 2000 ; 39: 1037-1043
23. Clark MS, McDevitt RA, Neumaier JF. Quantitative mapping of tryptophan hydroxylase-2, 5-HT1A, 5-HT1B, and serotonin transporter expression across the anteroposterior axis of the rat dorsal and median raphe nuclei. J Comp Neurol. 2006 ; 498: 611-623
24. De Almeida RMM, Giovenardi M, Charchat H, et al. 8-OH-DPAT in the median raphe nucleus decreases while in the medial septal area it may increase anxiety in female rats. Neurosci Biobehav Rev. 1998 ; 23: 259-264
25. Deakin JFW, Graeff FG. 5-HT and mechanisms of defence. J Psychopharmacol. 1991 ; 5: 305-315
26. Dos Santos L, Andrade TGCS, Graeff FG. Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus. J Psychopharmacol. 2010 ; 24: 725-731
27. Dos Santos L, Andrade TGCS, Zangrossi H. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety. Psychopharmacology. 2005 ; 179: 733-741
28. Dos Santos L, Andrade TGCS, Zangrossi H. 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus. Eur Neuropsychopharmacol. 2008 ; 18: 286-294
29. Dudley TE, DiNardo LA, Glass JD. Endogenous regulation of serotonin release in the hamster suprachiasmatic nucleus. J Neurosci. 1998 ; 18: 5045-5052
30. Dudley TE, DiNardo LA, Glass JD. In vivo assessment of the midbrain raphe nuclear regulation of serotonin release in the hamster suprachiasmatic nucleus. J Neurophysiol. 1999 ; 81: 1469-1477
31. Fanselow MS, Dong HW. Are the dorsal and ventral hippocampus functionally distinct structures?. Neuron. 2010 ; 65: 7-31
32. File SE, Gonzalez LE. Anxiolytic effects in the plus-maze of 5-HT1A-receptor ligands in dorsal raphé and ventral hippocampus. Pharmacol Biochem Behav. 1996 ; 54: 123-128
33. File SE, Gonzalez LE, Andrews N. Comparative study of pre and postsynaptic 5-HT1A receptor modulation of anxiety in two ethological animal tests. J Neurosci. 1996 ; 16: 4810-4815
34. File SE, Hyde JRG, Mc.Leod NK. 5,7-Dyhydroxytriptamine lesion of dorsal and median raphe nuclei and performance in the social interaction test of anxiety and in a home cage agression test. J Affect Disord. 1979 ; 1: 115-122
35. Forchetti CM, Meek JL. Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus. Brain Res. 1981 ; 206: 208-212
36. Gonzalez LE, Ouagazzal AM, File SE. Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety. Eur J Neurosci. 1998 ; 10: 3673-3680
37. Graeff FG, Silveira Filho G. Behavioral inhibition induced by electrical stimulation of the median raphe nucleus of the rat. Physiol Behav. 1978 ; 71: 477-484
38. Graeff FG, Zangrossi H Biological Psychiatry. D'Haenen H Den Boer JA Willner P, ed. Chichester: John Wiley and Sons, pp ; 2002: 879-893.
39. Graeff FG, Zangrossi H. The dual role of serotonin in defense and the mode of action of antidepressants on generalized anxiety and panic disorders. Cent Nerv Syst Agents Med Chem. 2010 ; 10: 207-217
40. Graeff FG, Ferreira Netto C, Zangrossi H. The elevated T-maze as an experimental model of anxiety. Neurosci Biobehav Rev. 1998 ; 23: 237-246
41. Graeff FG, Guimarães FS, Andrade TGCS, et al. Role of 5-HT in stress, anxiety and depression. Pharmacol Biochem Behav. 1996a ; 54: 129-141
42. Graeff FG, Quintero S, Gray JA. Median raphe stimulation, hippocampal theta rhythm and threat-induced behavioral inhibition. Physiol Behav. 1980 ; 25: 253-261
43. Graeff FG, Viana MB, Mora PO. Opposed regulation by dorsal raphe nucleus 5-HT pathways of two types of fear in the elevated T-maze. Pharmacol Biochem Behav. 1996b ; 53: 171-177
44. Graeff FG, Viana MB, Tomaz C. The elevated T maze, a new experimental model of anxiety and memory: Effect of diazepam. Braz J Med Biol Res. 1993 ; 26: 67-70
45. Gray JA The Neuropsychology of Anxiety: an Enquiry into the Function of the Septo-Hippocampal System. Oxford: Oxford University Press ; 1982:
46. Gray JA The Psychology of Fear and Stress. Cambridge: Cambridge University Press ; 1987:
47. Gray JA, McNaughton N The Neuropsychology of Anxiety. 2000 ) The Neuropsychology of Anxiety. 2nd ed.Oxford: University Press. Oxford: University Press ; 2000:
48. Hajós M, Gartside SE, Sharp T. Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine. Naunyn Schmiedebergs Arch Pharmacol. 1995 ; 351: 624-629
49. Hale MW, Lowry CA. Functional topography of midbrain and pontine serotonergic systems: Implications for synaptic regulation of serotonergic circuits. Psychopharmacology. 2011 ; 213: 243-264
50. Hale MW, Shekhar A, Lowry CA. Stress-related serotonergic systems: Implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol. 2012 ; 32: 695-708
51. Handley SL, Mithani S. Effects of alpha-adrenoceptor agonists and antagonists in a maze-exploration model of 'fear'-motivated behaviour. Naunyn Schmiedebergs Arch Pharmacol. 1984 ; 327: 1-5
52. Hensler JG. Serotonergic modulation of the limbic system. Neurosci Biobehav Rev. 2006 ; 30: 203-214
53. Higgins GA, Bradbury AJ, Jones BJ, et al. Behavioral and biochemical consequences following activation of the 5-HT1-like and GABA receptors in the dorsal raphe nucleus of the rat. Neuropharmacology. 1988 ; 27: 992-1001
54. Higgins GA, Jones BJ, Oakley NR. Effect of 5-HT1A agonist in two models of anxiety after dorsal raphe injection. Psychopharmacology. 1992 ; 106: 261-267
55. Hogg S, Andrews N, File SE. Contrasting behavioral effects of 8-OH-DPAT in the dorsal raphe nucleus and ventral hippocampus. Neuropharmacology. 1994 ; 33: 343-348
56. Jackson J, Dickson CT, Bland BH. Median raphe stimulation disrupts hippocampal theta via rapid inhibition and state-dependent phase reset of theta-related neural circuitry. J Neurophysiol. 2008 ; 99: 3009-3026
57. Judge SJ, Young RL, Gartside SE. GABAA receptor modulation of 5-HT neuronal firing in the median raphe nucleus: Implications for the action of anxiolytics. Eur Neuropsychopharmacol. 2006 ; 16: 612-619
58. Kirby LG, Pernar L, Valentino RJ, et al. Distinguishing characteristics of serotonina and non-serotonin-containing cells in the dorsal raphe nucleus: Electrophysiological and immunohistochemical studies. Neuroscience. 2003 ; 116: 669-683
59. Kiyasova V, Bonnavion P, Scotto-Lomassese S, et al. A subpopulation of serotonergic neurons that do not express the 5-HT1A autoreceptor. ACS. Chem Neurosci. 2013 ; 4: 89-95
60. Kreiss DS, Lucki I. Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei. J Pharmacol Exp Ther. 1994 ; 269: 1268-1279
61. Kurumaji A, Nishikawa T. An anxiogenic drug, FG 7142, induced an increase in mRNA of Btg2 and Adamts1 in the hippocampus of adult mice. Behav Brain Funct. 2012 ; 8: 43-50
62. Lechin F, Dijs BVD, Adrían GH. Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2006 ; 30: 565-585
63. Lowry CA. Functional subsets of serotonergic neurones: Implications for control of the hypothalamic-pituitary-adrenal axis. J Neuroendocrinol. 2002 ; 14: 911-923
64. Lowry CA, Matthew WH, Evans AK, et al. Serotonergic systems, anxiety, and affective disorder. Focus on the dorsomedial part of the dorsal raphe nucleus. Stress, Neurotransmitters, and Hormones: Annals of the New York Academy of Sciences. 2008 ; 1148: 86-94
65. McHugh SB, Campbell TG, Taylor AM, et al. A role for dorsal and ventral hippocampus in inter-temporal choice cost-benefit decision making. Behav Neurosci. 2008 ; 122: 1-8
66. McKenna JT, Vertes RP. Collateral projections from the median raphe nucleus to the medial septum and hippocampus. Brain Res Bull. 2001 ; 54: 619-630
67. McNaughton N, Zangrossi H Handbook of Anxiety and Fear. Blanchard RJ Blanchard CD Griebel G, ed. Oxford: Elsevier, pp ; 2008: 11-28.
68. McNaughton N, Kocsis B, Hajos M. Elicited hippocampal theta rhythm: A screen for anxiolytic and procognitive drugs through changes in hippocampal function?. Behav Pharmacol. 2007 ; 18: 329-346
69. Melik E, Babar-Melik E, Özgünen T, et al. Median raphe nucleus mediates forming long-term but not short term contextual fear conditioning in rats. Behav Brain Res. 2000 ; 112: 145-150
70. Merali Z, Bedard T, Andrews N, et al. Bombesin receptors as a novel anti-anxiety therapeutic target: BB1 receptor actions on anxiety through alterations of serotonin activity. J Neurosci. 2006 ; 26: 10387-10396
71. Netto SM, Silveira R, Coimbra NC, et al. Anxiogenic effect of median raphe nucleus lesion in stressed rats. Prog Neuropsychopharmacol Biol Psychiatry. 2002 ; 26: 1135-1141
72. Nitz DA, McNaughton BL. Hippocampal EEG and unit activity responses to modulation of serotonergic median raphe neurons in the freely behaving rat. Learn Mem. 1999 ; 6: 153-167
73. Nunes-de-Souza V, Nunes-de-Souza R, Rodgers RJ, et al. Blockade of 5-HT2 receptors in the periaqueductal grey matter (PAG) abolishes the anxiolytic-like effect of 5-HT1A receptor antagonism in the median raphe nucleus in mice. Behav Brain Res. 2011 ; 225: 547-553
74. Ögren SO, Eriksson TM, Elvander-Tottie E, et al. The role of 5-HT1A receptors in learning and memory. Behav Brain Res. 2008 ; 195: 54-77
75. Paul ED, Lowry CA. Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J Psychopharmacol. 2013 2013 ;:
76. Pellow S, Chopin P, File SE, et al. Validation of open-closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods. 1985 ; 14: 149-167
77. Picazo O, López-Rubalcava C, Fernández-Guasti A. Anxiolytic effect of the 5HT1A compounds 8-Hydroxy-2-(di-n-Propylamino) tetralin and ipsapirone in the social interaction paradigm: Evidence of presynaptic action. Brain Res Bull. 1995 ; 37: 169-175
78. Pinheiro SH, Zangrossi H, Del Ben CM, et al. Elevated mazes as animal models of anxiety: Effects of serotonergic agents. An Acad Bras Cienc. 2007 ; 79: 71-85
79. Pobbe RLH, Zangrossi H. 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray mediate the antipanic-like effect induced by the stimulation of serotonergic neurons in the dorsal raphe nucleus. Psychopharmacology. 2005 ; 183: 314-321
80. Pobbe RL, Zangrossi H, Blanchard DC, et al. Involvement of dorsal raphe nucleus and dorsal periaqueductal gray 5-HT receptors in the modulation of mouse defensive behaviors. Eur Neuropsychopharmacol. 2011 ; 21: 306-315
81. Poltronieri S, Zangrossi H, Viana MB. Antipanic-like effect of serotonin reuptake inhibitors in the elevated T-maze. Behav Brain Res. 2003 ; 147: 185-192
82. Remy SM, Schreiber R, Dalmus M, et al. Somatodendritic 5-HT1A receptors are critically involved in the anxiolytic effects of 8-OH-DPAT. Psychopharmacology. 1996 ; 125: 89-91
83. Schreiber R, De Vry JD. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT, ipsapirone and buspirone in the rat. Eur J Pharmacol. 1993 ; 249: 341-351
84. Sena LM, Bueno C, Pobbe RLH, et al. The dorsal raphe nucleus exerts opposed control on generalized anxiety and panic-related defensive responses in rats. Behav Brain Res. 2003 ; 142: 125-133
85. Silva RCB, Cruz APM, Avanzi V, et al. Distinct contributions of median raphe nucleus to contextual fear conditioning and fear-potentiated startle. Neural Plast. 2002 ; 9: 233-247
86. Silva RCB, Gárgaro AC, Brandão ML. Differential regulation of the expression of contextual freezing and fear-potentiated startle by 5-HT mechanisms of the median raphe nucleus. Behav Brain Res. 2004 ; 151: 93-101
87. Spiacci A, Coimbra NC, Zangrossi H. Differential involvement of dorsal raphe subnuclei in the regulation of anxiety- and panic-related defensive behaviors. Neuroscience. 2012 ; 227: 350-360
88. Tao R, Auberach SB. Regulation of serotonin release by GABA and excitatory amino acids. J Psychopharmacol. 2000 ; 14: 100-113
89. Teixeira RC, Zangrossi H, Graeff FG. Behavioral effects of acute and chronic imipramine in the elevated T maze model of anxiety. Pharmacol Biochem Behav. 2000 ; 65: 571-576
90. Thiébot MH, Soubrié P, Sanger D. Anxiogenic properties of beta-CCE and FG 7142: A review of promises and pitfalls. Psychopharmacology. 1988 ; 94: 452-463
91. Thomas H, Fink H, Sohr R, et al. Lesion of the median raphe nucleus. A combined behavioural and microdialysis study in rats. Pharmacol Biochem Behav. 2000 ; 65: 15-21
92. Vasudeva RK, Lin RCS, Simpson KL, et al. Functional organization of the dorsal raphe efferent system with special consideration of nitrergic cell groups. J Chem Neuroanat. 2011 ; 41: 281-293
93. Vertes RP. An analysis of ascending brain stem systems involved in hippocampal synchronization and desynchronization. J Neurophysiol. 1981 ; 46: 1140-1159
94. Vertes RP, Fortin WJ, Crane AM. Projections of the median raphe nucleus in the rat. J Comp Neurol. 1999 ;: 555-582
95. Viana MB, Tomaz C, Graeff FG. The elevated T-maze: A new animal model of anxiety and memory. Pharmacol Biochem Behav. 1994 ; 49: 549-554
96. Vicente MA, Zangrossi Jr H, Santos L, et al. nvolvement of median raphe nucleus 5-HT1A receptors in the regulation of generalized anxiety-related defensive behaviours in rats. Neurosci Lett. 2008 ; 445: 204-208
97. Waselus M, Valentino RJ, Van Bockstaele EJ. Collateralized dorsal raphe nucleus projections: A mechanism for the integration of diverse functions during stress. J Chem Neuroanat. 2011 ; 41: 266-280
98. Wirtshafter D, McWilliams C. Supression of locomotor activity produced by acute injections of the kainic acid into the median raphe nucleus. Brain Res. 1987 ; 408: 349-352
99. Zangrossi H, Graeff FG. Behavioral validation of the elevated T-maze, a new animal model of anxiety. Brain Res Bull. 1997 ; 44: 1-5
100. Zelikowsky M. Bissiere S. Hast T.A. Prefrontal microcircuit underlies contextual learning after hippocampal loss Proc Natl Acad Sci U S A. 2013. 110 9938-9943.